References
Maxwell MH, Frishman WH, Kong BW. Quality-of-life considerations for first-line antihypertensive therapy. Cardiovasc Rev Rep 1994 May; 15: 17–23
Hollenberg NK, Testa M, Williams GH. Quality of life as a therapeutic end-point: an analysis of therapeutic trials in hypertension. Drug Saf 1991; 6(2); 83–93
Bulpitt CJ, Fletcher AE. Quality-of-life instruments in hypertension. PharmacoEconomics 1994; 6(6): 523–35
Kong BW, Clive J, Komg SH. Quality of life as a vital clinical sign. J Hum Hypertens 1990; 4: 121–3
Bansal VK, Beto JA. Antihypertensive therapy: quality of life assessment. Cardiovasc Rev Rep 1994 Dec; 15; 21–31
Wiklund I. Quality of life and cost-effectiveness in the treatment of hypertension. J Clin Pharm Ther 1994; 19: 81–7
Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314(26): 1657–64
Bulpitt CJ, Fletcher AE. Quality of life evaluation of antihypertensive drugs. PharmacoEconomics 1992; 1(2): 95–102
Dzau VJ. Treatment strategies: an evaluation of antihypertensive therapy. Am J Med 1989 Jan 23; 86 Suppl. 1B: 113–5
Wassertbeil-Smoller S, Blaufox MD, Oberman A et al. Effect of antihypertensives on sexual function and quality of life: the TAIM Study. Am Coll Physicians 1991 Apr 15; 114(8): 613–20
Bech P. Quality of life measurements for patients taking which drugs? PharmacoEconomics 1995; 7(2): 141–51
Bulpitt CJ, Fletcher AE. Measurement of quality of life in hypertensive patients. Br J Clin Pharmacol 1990; 30: 353–64
Dahlöf C, Dimenäs E, Olofsson B. Documentation of an instrument for assessment of subjective CNS-related symptoms during cardiovascular pharmacotherapy. Cardiovasc Drugs Ther 1989; 3: 919–27
Rights and permissions
About this article
Cite this article
Instruments used to assess QOL in patients with hypertension. Drugs Ther. Perspect 5, 14–16 (1995). https://doi.org/10.2165/00042310-199505110-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199505110-00006